Phase I trial of chimerized anti-epidermal growth factor receptor antibody in combination with either once-daily or twice-daily irradiation for locally advanced head and neck malignancies. (Ref Type: Abstract). - Ezekiel,M.P.; Bonner,J.A.; Robert,F. (Proc Am Soc Clin Oncol)